vs

Side-by-side financial comparison of IONIS PHARMACEUTICALS INC (IONS) and Sun Country Airlines Holdings, Inc. (SNCY). Click either name above to swap in a different company.

Sun Country Airlines Holdings, Inc. is the larger business by last-quarter revenue ($281.0M vs $203.3M, roughly 1.4× IONIS PHARMACEUTICALS INC). Sun Country Airlines Holdings, Inc. runs the higher net margin — 2.9% vs -112.8%, a 115.7% gap on every dollar of revenue. On growth, Sun Country Airlines Holdings, Inc. posted the faster year-over-year revenue change (7.9% vs -10.3%). Sun Country Airlines Holdings, Inc. produced more free cash flow last quarter ($34.9M vs $-159.0M). Over the past eight quarters, IONIS PHARMACEUTICALS INC's revenue compounded faster (30.4% CAGR vs -5.0%).

Ionis Pharmaceuticals, Inc. is a biotechnology company that specializes in discovering and developing antisense therapy, as well as RNA interference and CRISPR therapeutics. The company was founded in 1989 is based in Carlsbad, California. The company was previously known as Isis Pharmaceuticals until December 2015.

Frontier Airlines, Inc. is a major American ultra low-cost airline headquartered in Denver, Colorado. It operates flights to over 120 destinations in the United States, the Caribbean, Mexico and Central America, and employs more than 5,000 staff. The carrier is a publicly traded company and maintains bases at Denver International Airport, Orlando International Airport, and eleven other cities across the contiguous United States and Puerto Rico.

IONS vs SNCY — Head-to-Head

Bigger by revenue
SNCY
SNCY
1.4× larger
SNCY
$281.0M
$203.3M
IONS
Growing faster (revenue YoY)
SNCY
SNCY
+18.2% gap
SNCY
7.9%
-10.3%
IONS
Higher net margin
SNCY
SNCY
115.7% more per $
SNCY
2.9%
-112.8%
IONS
More free cash flow
SNCY
SNCY
$193.9M more FCF
SNCY
$34.9M
$-159.0M
IONS
Faster 2-yr revenue CAGR
IONS
IONS
Annualised
IONS
30.4%
-5.0%
SNCY

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
IONS
IONS
SNCY
SNCY
Revenue
$203.3M
$281.0M
Net Profit
$-229.4M
$8.1M
Gross Margin
96.1%
Operating Margin
-105.5%
6.5%
Net Margin
-112.8%
2.9%
Revenue YoY
-10.3%
7.9%
Net Profit YoY
-119.8%
-39.4%
EPS (diluted)
$-1.35
$0.15

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
IONS
IONS
SNCY
SNCY
Q4 25
$203.3M
$281.0M
Q3 25
$156.7M
$255.5M
Q2 25
$452.0M
$263.6M
Q1 25
$131.6M
$326.6M
Q4 24
$226.6M
$260.4M
Q3 24
$133.8M
$249.5M
Q2 24
$225.3M
$254.4M
Q1 24
$119.5M
$311.5M
Net Profit
IONS
IONS
SNCY
SNCY
Q4 25
$-229.4M
$8.1M
Q3 25
$-128.6M
$1.6M
Q2 25
$123.6M
$6.6M
Q1 25
$-146.9M
$36.5M
Q4 24
$-104.3M
$13.4M
Q3 24
$-140.5M
$2.3M
Q2 24
$-66.3M
$1.8M
Q1 24
$-142.8M
$35.3M
Gross Margin
IONS
IONS
SNCY
SNCY
Q4 25
96.1%
Q3 25
98.5%
Q2 25
99.1%
Q1 25
98.9%
Q4 24
98.3%
Q3 24
99.2%
Q2 24
98.2%
Q1 24
98.2%
Operating Margin
IONS
IONS
SNCY
SNCY
Q4 25
-105.5%
6.5%
Q3 25
-102.2%
3.9%
Q2 25
30.9%
6.2%
Q1 25
-111.6%
17.2%
Q4 24
-48.9%
10.0%
Q3 24
-111.1%
5.0%
Q2 24
-29.3%
4.9%
Q1 24
-125.1%
17.7%
Net Margin
IONS
IONS
SNCY
SNCY
Q4 25
-112.8%
2.9%
Q3 25
-82.1%
0.6%
Q2 25
27.3%
2.5%
Q1 25
-111.6%
11.2%
Q4 24
-46.1%
5.2%
Q3 24
-105.0%
0.9%
Q2 24
-29.4%
0.7%
Q1 24
-119.5%
11.3%
EPS (diluted)
IONS
IONS
SNCY
SNCY
Q4 25
$-1.35
$0.15
Q3 25
$-0.80
$0.03
Q2 25
$0.70
$0.12
Q1 25
$-0.93
$0.66
Q4 24
$-0.66
$0.25
Q3 24
$-0.95
$0.04
Q2 24
$-0.45
$0.03
Q1 24
$-0.98
$0.64

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
IONS
IONS
SNCY
SNCY
Cash + ST InvestmentsLiquidity on hand
$2.7B
$234.3M
Total DebtLower is stronger
$1.8B
$323.3M
Stockholders' EquityBook value
$489.1M
$625.2M
Total Assets
$3.5B
$1.7B
Debt / EquityLower = less leverage
3.71×
0.52×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
IONS
IONS
SNCY
SNCY
Q4 25
$2.7B
$234.3M
Q3 25
$2.2B
$176.2M
Q2 25
$2.3B
$138.3M
Q1 25
$2.1B
$158.8M
Q4 24
$2.3B
$187.3M
Q3 24
$2.5B
$146.5M
Q2 24
$2.1B
$135.2M
Q1 24
$2.2B
$161.2M
Total Debt
IONS
IONS
SNCY
SNCY
Q4 25
$1.8B
$323.3M
Q3 25
$301.3M
Q2 25
$282.1M
Q1 25
$312.6M
Q4 24
$1.3B
$327.1M
Q3 24
$351.8M
Q2 24
$365.5M
Q1 24
$388.1M
Stockholders' Equity
IONS
IONS
SNCY
SNCY
Q4 25
$489.1M
$625.2M
Q3 25
$618.0M
$610.2M
Q2 25
$631.7M
$613.0M
Q1 25
$475.7M
$603.0M
Q4 24
$588.4M
$570.4M
Q3 24
$662.5M
$552.5M
Q2 24
$263.7M
$546.9M
Q1 24
$296.5M
$541.0M
Total Assets
IONS
IONS
SNCY
SNCY
Q4 25
$3.5B
$1.7B
Q3 25
$3.0B
$1.6B
Q2 25
$3.0B
$1.6B
Q1 25
$2.8B
$1.6B
Q4 24
$3.0B
$1.6B
Q3 24
$3.1B
$1.6B
Q2 24
$2.7B
$1.6B
Q1 24
$2.8B
$1.6B
Debt / Equity
IONS
IONS
SNCY
SNCY
Q4 25
3.71×
0.52×
Q3 25
0.49×
Q2 25
0.46×
Q1 25
0.52×
Q4 24
2.13×
0.57×
Q3 24
0.64×
Q2 24
0.67×
Q1 24
0.72×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
IONS
IONS
SNCY
SNCY
Operating Cash FlowLast quarter
$-137.7M
$78.9M
Free Cash FlowOCF − Capex
$-159.0M
$34.9M
FCF MarginFCF / Revenue
-78.2%
12.4%
Capex IntensityCapex / Revenue
10.5%
15.7%
Cash ConversionOCF / Net Profit
9.69×
TTM Free Cash FlowTrailing 4 quarters
$-320.0M
$84.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
IONS
IONS
SNCY
SNCY
Q4 25
$-137.7M
$78.9M
Q3 25
$-131.4M
$41.9M
Q2 25
$151.3M
$19.8M
Q1 25
$-150.8M
$16.4M
Q4 24
$-116.1M
$90.6M
Q3 24
$-115.0M
$35.4M
Q2 24
$-119.9M
$8.2M
Q1 24
$-149.9M
$30.7M
Free Cash Flow
IONS
IONS
SNCY
SNCY
Q4 25
$-159.0M
$34.9M
Q3 25
$-136.7M
$34.0M
Q2 25
$139.0M
$14.0M
Q1 25
$-163.4M
$1.0M
Q4 24
$-141.6M
$85.8M
Q3 24
$-124.0M
$31.0M
Q2 24
$-126.1M
$-382.0K
Q1 24
$-154.4M
$1.0M
FCF Margin
IONS
IONS
SNCY
SNCY
Q4 25
-78.2%
12.4%
Q3 25
-87.2%
13.3%
Q2 25
30.8%
5.3%
Q1 25
-124.1%
0.3%
Q4 24
-62.5%
33.0%
Q3 24
-92.7%
12.4%
Q2 24
-56.0%
-0.2%
Q1 24
-129.2%
0.3%
Capex Intensity
IONS
IONS
SNCY
SNCY
Q4 25
10.5%
15.7%
Q3 25
3.4%
3.1%
Q2 25
2.7%
2.2%
Q1 25
9.6%
4.7%
Q4 24
11.3%
1.8%
Q3 24
6.8%
1.8%
Q2 24
2.8%
3.4%
Q1 24
3.8%
9.5%
Cash Conversion
IONS
IONS
SNCY
SNCY
Q4 25
9.69×
Q3 25
27.03×
Q2 25
1.22×
3.01×
Q1 25
0.45×
Q4 24
6.74×
Q3 24
15.13×
Q2 24
4.50×
Q1 24
0.87×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

IONS
IONS

Products$58.0M29%
Spinraza Royalties$54.0M27%
Collaborative Agreement Revenue$52.4M26%
Wainus Royalties$16.0M8%
Wainua Joint Development Revenue$9.6M5%
Other Commercial$7.6M4%
Other Royalties$5.7M3%

SNCY
SNCY

Scheduled Service$95.6M34%
Ancillary$69.3M25%
Charter Service$56.6M20%
Cargo And Freight$48.0M17%
Service Other$11.4M4%

Related Comparisons